Personalized Medicine as Innovation
What Can Germany Learn from the USA
(Sprache: Englisch)
Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
Fr. 59.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Personalized Medicine as Innovation “
Klappentext zu „Personalized Medicine as Innovation “
Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. - as early knower - have the most projects as well as personalized drugs and therapies, while Germany - as a follower - has a significant number of projects and personalized products and more to come in future.
Inhaltsverzeichnis zu „Personalized Medicine as Innovation “
Personalized Medicine Background.- The United States of America as Early Knower.- Germany as Follower.- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.
Autoren-Porträt von Katharina Kichko
Katharina Kichko has written this book within her PhD program at the University of Greifswald.
Bibliographische Angaben
- Autor: Katharina Kichko
- 2019, 1st ed. 2019, XXV, 354 Seiten, Masse: 14,9 x 21,1 cm, Kartoniert (TB), Englisch
- Verlag: Springer, Berlin
- ISBN-10: 3658278420
- ISBN-13: 9783658278427
Sprache:
Englisch
Kommentar zu "Personalized Medicine as Innovation"
0 Gebrauchte Artikel zu „Personalized Medicine as Innovation“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Personalized Medicine as Innovation".
Kommentar verfassen